article · Naunyn-Schmiedeberg s Archives of Pharmacology

Duloxetine as a gut-brain axis modulator in irritable bowel syndrome: neuroimmune, microbiota, and pharmacogenomic perspectives

Mokhtar Rejili
Thabat J. Al‐Maiahy
Hayder M. Al‐kuraishy
Ali K. Albuhadily
Aya M. Mustafa
Nawar R. Hussein
Ali I. Al‐Gareeb
Gaber El-Saber Batiha

2026Egyptian Russian University

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Gastrointestinal motility and disorders
Vagus Nerve Stimulation Research
Treatment of Major Depression

Sustainable Development Goals

Zero Hunger

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1007/s00210-026-05419-1

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.